Physician compensation, 2026

Endocrinology Salary

Endocrinology is a cognitive specialty with a lower procedural ceiling than other internal medicine subspecialties, so the comp story is about volume efficiency and the care-management and device revenue layered on a diabetes and obesity panel.

National median
$260,000
Typical range (p10 to p90)
$220k to $310k
Median annual wRVUs
5,200
Call burden
Low

Median total cash compensation for a mid-career attending. Source: Medscape 2024 (publicly cited). Treat figures as medians, not targets. Real compensation varies widely by geography, employment model, and experience.

Live anonymous cohort, Endocrinology

This cohort is still being built.

We display a live Endocrinology cohort once at least 10 attendings have submitted in the last 24 months. Until then, the published benchmark and regional table below are your reference. Be one of the first to seed it.

Submit your comp anonymously

Endocrinology pay by region

Directional regional medians, anchored to the Medscape 2024 national figure and US Census region adjustments. The South and Midwest pay more in absolute dollars because physician supply is lower and demand is higher; the Northeast runs lower with a higher cost of living.

RegionMedian total compNotes
National median$260,000Doximity 2024 / Medscape 2024 nationwide median.
South$286,000Highest absolute compensation. Houston, Jacksonville, Charlotte, Atlanta lead.
Midwest$280,800Indianapolis and St. Louis often top Doximity median tables.
West$265,200Wide spread. California pays well but is offset by cost of living.
Northeast$252,200Lower in absolute terms (high supply of physicians) and higher cost of living.

Regional figures are modeled adjustments to the national median, not separately surveyed values. Use them for direction, not as an offer benchmark.

What drives Endocrinology compensation

  • Visit efficiency and panel composition, since income tracks cognitive E/M volume more than procedures.
  • Continuous glucose monitor interpretation and diabetes education revenue attached to the panel.
  • Chronic care and remote monitoring programs, which add recurring wRVUs without new visit slots.
  • Demand tailwinds from type 2 diabetes and obesity care, which improve leverage in negotiations.

Model your own number, not the median

Endocrinology reports a median of about 5,200 wRVUs a year. Your take-home is that volume times your contract rate, above your threshold. Plug your real visit mix into the calculator and see the bonus your specific offer produces, then negotiate against it.

Negotiation levers at offer time

  • Because procedures will not carry income, focus the offer on a fair wRVU rate and a reachable threshold.
  • Confirm that CGM interpretation and care-management codes credit to your production.
  • Use the strong demand for endocrinology as leverage on base and start date flexibility.

Endocrinology at a glance

Median total comp
$260,000
Clinical hours / week
50
Fellowship years
2
Median annual wRVUs
5,200
Private practice share
18%
Call burden
Low

Lower comp ceiling than other IM subs. Growing demand from T2DM and obesity care. Typical setting: outpatient clinic, low procedural mix.

Frequently asked questions

Why does endocrinology pay less than other IM subspecialties?

It is largely non-procedural, so income depends on cognitive visit volume rather than high-wRVU procedures. The lever is efficiency and the care-management revenue around a diabetes and obesity panel.

Can care management meaningfully raise endocrinology income?

Yes. CGM interpretation, chronic care management, and remote monitoring add recurring wRVUs to an existing panel without requiring additional visit slots.

Is endocrinology demand improving the negotiating position?

The growth in type 2 diabetes and obesity care has tightened supply relative to demand, which generally improves leverage on base and flexibility.

Keep going

Educational reference, not financial, billing, or legal advice. Published medians are publicly cited from Medscape 2024. The live cohort is self-reported and anonymized; individual rows are never exposed and a cohort is shown only at a minimum size. Verify any number against your own contract and market before acting on it.